Solvay SA (OTC:SLVYY – Get Free Report) has been assigned a consensus recommendation of “Reduce” from the six brokerages that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company.
Several research analysts have recently issued reports on SLVYY shares. Oddo Bhf cut Solvay to a “neutral” rating in a research note on Tuesday, February 17th. Sanford C. Bernstein cut shares of Solvay to a “market perform” rating in a research note on Thursday, January 8th. Barclays reaffirmed an “underweight” rating on shares of Solvay in a report on Wednesday, February 25th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Solvay from a “hold” rating to a “sell” rating in a research report on Monday, November 24th.
Check Out Our Latest Analysis on Solvay
Solvay Stock Performance
Solvay Company Profile
Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aerospace, and healthcare industries; and composite materials for aerospace engineered materials market. The Chemicals segment produces and sells soda ash and sodium bicarbonate primarily to the flat and container glass industries, as well as for use in detergents, pharmaceutical, and feed and food industries; hydrogen peroxide for use primarily in the paper industry to bleach pulp, as well as chemicals, electronics, food, mining, and environment; and dispersible silica for tire manufacturers; and solvent solutions, phenols and derivatives, polyamide derivatives and smart, functional, and sustainable yarns and polymers.
Read More
- Five stocks we like better than Solvay
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Iran isn’t the real war
- This coin has everything going for it
Receive News & Ratings for Solvay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solvay and related companies with MarketBeat.com's FREE daily email newsletter.
